SEARCH

SEARCH BY CITATION

References

  • Asensi, M., Medina, I., Ortega, A., Carretero, J., Bano, M.C., Obrador, E., and Estrela, J.M. (2002). Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 33, 387398.
  • Bachmeier, B.E., Iancu, C.M., Killian, P.H., Kronski, E., Mirisola, V., Angelini, G., Jochum, M., Nerlich, A.G., and Pfeffer, U. (2009). Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cells. Mol. Cancer 8, 129.
  • Bakhshi, J., Weinstein, L., Poksay, K.S., Nishinaga, B., Bredesen, D.E., and Rao, R.V. (2008). Coupling endoplasmic reticulum stress to the cell death program in mouse melanoma cells: effect of curcumin. Apoptosis 13, 904914.
  • Banerji, A., Chakrabarti, J., Mitra, A., and Chatterjee, A. (2004). Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Lett. 211, 235242.
  • Belleri, M., Ribatti, D., Savio, M. et al. (2008). alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. Mol. Cancer Ther. 7, 37613770.
  • Bill, M.A., Bakan, C., Benson Jr, D.M., Fuchs, J., Young, G., and Lesinski, G.B. (2009). Curcumin induces proapoptotic effects against human melanoma cells and modulates the cellular response to immunotherapeutic cytokines. Mol. Cancer Ther. 8, 27262735.
  • Bush, J.A., Cheung Jr, K.J., and Li, G. (2001). Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp. Cell Res. 271, 305314.
  • Caltagirone, S., Rossi, C., Poggi, A., Ranelletti, F.O., Natali, P.G., Brunetti, M., Aiello, F.B., and Piantelli, M. (2000). Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int. J. Cancer 87, 595600.
  • Cardile, V., Chillemi, R., Lombardo, L., Sciuto, S., Spatafora, C., and Tringali, C. (2007). Antiproliferative activity of methylated analogues of E- and Z-resveratrol. Z. Naturforsch. C 62, 189195.
  • Casagrande, F., and Darbon, J.M. (2000). p21CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells. Exp. Cell Res. 258, 101108.
  • Chatterjee, S.J., and Pandey, S. (2011). Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy. Cancer Biol. Ther. 11, 216228.
  • Constantinou, A., and Huberman, E. (1995). Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc. Soc. Exp. Biol. Med. 208, 109115.
  • Darbon, J.M., Penary, M., Escalas, N., Casagrande, F., Goubin-Gramatica, F., Baudouin, C., and Ducommun, B. (2000). Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells. J. Biol. Chem. 275, 1536315369.
  • Egan, K.M. (2009). Vitamin D and melanoma. Ann. Epidemiol. 19, 455461.
  • Farina, H.G., Pomies, M., Alonso, D.F., and Gomez, D.E. (2006). Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol. Rep. 16, 885891.
  • Francis, S.O., Mahlberg, M.J., Johnson, K.R., Ming, M.E., and Dellavalle, R.P. (2006). Melanoma chemoprevention. J. Am. Acad. Dermatol. 55, 849861.
  • Fuggetta, M.P., D’atri, S., Lanzilli, G., Tricarico, M., Cannavo, E., Zambruno, G., Falchetti, R., and Ravagnan, G. (2004). In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide. Melanoma Res. 14, 189196.
  • Fuke, Y., Shinoda, S., Nagata, I., Sawaki, S., Murata, M., Ryoyama, K., Koizumi, K., Saiki, I., and Nomura, T. (2006). Preventive effect of oral administration of 6-(methylsulfinyl)hexyl isothiocyanate derived from wasabi (Wasabia japonica Matsum) against pulmonary metastasis of B16-BL6 mouse melanoma cells. Cancer Detect. Prev. 30, 174179.
  • Fulda, S., and Debatin, K.M. (2004). Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 64, 337346.
  • Gandini, S., Raimondi, S., Gnagnarella, P., Dore, J.F., Maisonneuve, P., and Testori, A. (2009). Vitamin D and skin cancer: a meta-analysis. Eur. J. Cancer 45, 634641.
  • Garraway, L.A., Widlund, H.R., Rubin, M.A. et al. (2005). Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436, 117122.
  • Gatouillat, G., Balasse, E., Joseph-Pietras, D., Morjani, H., and Madoulet, C. (2010). Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma. J. Cell. Biochem. 110, 893902.
  • Guo, T.L., Mccay, J.A., Zhang, L.X., Brown, R.D., You, L., Karrow, N.A., Germolec, D.R., and White Jr, K.L. (2001). Genistein modulates immune responses and increases host resistance to B16F10 tumor in adult female B6C3F1 mice. J. Nutr. 131, 32513258.
  • Hakimzadeh, H., Ghazanfari, T., Rahmati, B., and Naderimanesh, H. (2010). Cytotoxic effect of garlic extract and its fractions on Sk-mel3 melanoma cell line. Immunopharmacol. Immunotoxicol. 32, 371375.
  • Hata, K., Ishikawa, K., Hori, K., and Konishi, T. (2000). Differentiation-inducing activity of lupeol, a lupane-type triterpene from Chinese dandelion root (Hokouei-kon), on a mouse melanoma cell line. Biol. Pharm. Bull. 23, 962967.
  • Hata, K., Hori, K., and Takahashi, S. (2003). Role of p38 MAPK in lupeol-induced B16 2F2 mouse melanoma cell differentiation. J. Biochem. 134, 441445.
  • Hata, K., Hori, K., Murata, J., and Takahashi, S. (2005). Remodeling of actin cytoskeleton in lupeol-induced B16 2F2 cell differentiation. J. Biochem. 138, 467472.
  • Hata, K., Mukaiyama, T., Tsujimura, N., Sato, Y., Kosaka, Y., Sakamoto, K., and Hori, K. (2006). Differentiation-inducing activity of lupane triterpenes on a mouse melanoma cell line. Cytotechnology 52, 151158.
  • Heng, M.C. (2010). Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy. Int. J. Dermatol. 49, 608622.
  • Hsieh, T.C., Wang, Z., Hamby, C.V., and Wu, J.M. (2005). Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53. Biochem. Biophys. Res. Commun. 334, 223230.
  • Ishige, K., Schubert, D., and Sagara, Y. (2001). Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med. 30, 433446.
  • Ivanov, V.N., Partridge, M.A., Johnson, G.E., Huang, S.X., Zhou, H., and Hei, T.K. (2008). Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Exp. Cell Res. 314, 11631176.
  • Jankun, J., Selman, S.H., Aniola, J., and Skrzypczak-Jankun, E. (2006). Nutraceutical inhibitors of urokinase: potential applications in prostate cancer prevention and treatment. Oncol. Rep. 16, 341346.
  • Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010). Cancer statistics, 2010. CA Cancer J Clin 60, 277300.
  • Jiang, Y.Y., Wang, H.J., Wang, J., Tashiro, S., Onodera, S., and Ikejima, T. (2009). The protective effect of silibinin against mitomycin C-induced intrinsic apoptosis in human melanoma A375-S2 cells. J. Pharmacol. Sci. 111, 137146.
  • Johnson, G.E., Ivanov, V.N., and Hei, T.K. (2008). Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival. Apoptosis 13, 790802.
  • Kang, T.H., Lee, J.H., Song, C.K. et al. (2007). Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res. 67, 802811.
  • Kast, R.E. (2008). Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma. Cancer Biol. Ther. 7, 15151519.
  • Kiguchi, K., Constantinou, A.I., and Huberman, E. (1990). Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells. Cancer Commun. 2, 271277.
  • Kim, Y.M., Yun, J., Lee, C.K., Lee, H., Min, K.R., and Kim, Y. (2002). Oxyresveratrol and hydroxystilbene compounds. Inhibitory effect on tyrosinase and mechanism of action. J. Biol. Chem. 277, 1634016344.
  • Kim, D.S., Park, S.H., Kwon, S.B., Li, K., Youn, S.W., and Park, K.C. (2004). (−)-Epigallocatechin-3-gallate and hinokitiol reduce melanin synthesis via decreased MITF production. Arch. Pharm. Res. 27, 334339.
  • Kim, H.Y., Kim, J.H., Yang, S.B., Hong, S.G., Lee, S.A., Hwang, S.J., Shin, K.S., Suh, H.J., and Park, M.H. (2007). A polysaccharide extracted from rice bran fermented with Lentinus edodes enhances natural killer cell activity and exhibits anticancer effects. J. Med. Food 10, 2531.
  • Kimira, M., Arai, Y., Shimoi, K., and Watanabe, S. (1998). Japanese intake of flavonoids and isoflavonoids from foods. J. Epidemiol. 8, 168175.
  • Larrosa, M., Tomas-Barberan, F.A., and Espin, J.C. (2003). Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. J. Agric. Food. Chem. 51, 45764584.
  • Larrosa, M., Tomas-Barberan, F.A., and Espin, J.C. (2004). The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells. Eur. J. Nutr. 43, 275284.
  • Lee, J.H., Jang, J.Y., Park, C., Kim, B.W., Choi, Y.H., and Choi, B.T. (2010a). Curcumin suppresses alpha-melanocyte stimulating hormone-stimulated melanogenesis in B16F10 cells. Int. J. Mol. Med. 26, 101106.
  • Lee, J.H., Kishikawa, M., Kumazoe, M., Yamada, K., and Tachibana, H. (2010b). Vitamin A enhances antitumor effect of a green tea polyphenol on melanoma by upregulating the polyphenol sensing molecule 67-kDa laminin receptor. PLoS One 5, e11051.
  • Lentini, A., Forni, C., Provenzano, B., and Beninati, S. (2007). Enhancement of transglutaminase activity and polyamine depletion in B16-F10 melanoma cells by flavonoids naringenin and hesperitin correlate to reduction of the in vivo metastatic potential. Amino Acids 32, 95100.
  • Leyon, P.V., and Kuttan, G. (2003). Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J. Exp. Clin. Cancer Res. 22, 7783.
  • Li, D., Yee, J.A., Mcguire, M.H., Murphy, P.A., and Yan, L. (1999). Soybean isoflavones reduce experimental metastasis in mice. J. Nutr. 129, 10751078.
  • Li, L.H., Wu, L.J., Tashiro, S.I., Onodera, S., Uchiumi, F., and Ikejima, T. (2006). The roles of Akt and MAPK family members in silymarin’s protection against UV-induced A375-S2 cell apoptosis. Int. Immunopharmacol. 6, 190197.
  • Li, L.H., Wu, L.J., Jiang, Y.Y., Tashiro, S., Onodera, S., Uchiumi, F., and Ikejima, T. (2007a). Silymarin enhanced cytotoxic effect of anti-Fas agonistic antibody CH11 on A375-S2 cells. J. Asian Nat. Prod. Res. 9, 593602.
  • Li, L.H., Wu, L.J., Tashiro, S.I., Onodera, S., Uchiumi, F., and Ikejima, T. (2007b). Activation of the SIRT1 pathway and modulation of the cell cycle were involved in silymarin’s protection against UV-induced A375-S2 cell apoptosis. J. Asian Nat. Prod. Res. 9, 245252.
  • Liu, J.D., Chen, S.H., Lin, C.L., Tsai, S.H., and Liang, Y.C. (2001). Inhibition of melanoma growth and metastasis by combination with (−)-epigallocatechin-3-gallate and dacarbazine in mice. J. Cell. Biochem. 83, 631642.
  • Lluria-Prevatt, M., Morreale, J., Gregus, J., Alberts, D.S., Kaper, F., Giaccia, A., and Powell, M.B. (2002). Effects of perillyl alcohol on melanoma in the TPras mouse model. Cancer Epidemiol. Biomarkers Prev. 11, 573579.
  • Ma, Z., Haddadi, A., Molavi, O., Lavasanifar, A., Lai, R., and Samuel, J. (2008). Micelles of poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J. Biomed. Mater. Res. A 86, 300310.
  • Mackie, R.M., Hauschild, A., and Eggermont, A.M. (2009). Epidemiology of invasive cutaneous melanoma. Ann. Oncol. 20(Suppl. 6), vi1vi7.
  • Maher, P., Akaishi, T., and Abe, K. (2006). Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc. Natl Acad. Sci. U S A 103, 1656816573.
  • Marin, Y.E., Wall, B.A., Wang, S. et al. (2007). Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res. 17, 274283.
  • Meeran, S.M., Mantena, S.K., and Katiyar, S.K. (2006). Prevention of ultraviolet radiation-induced immunosuppression by (−)-epigallocatechin-3-gallate in mice is mediated through interleukin 12-dependent DNA repair. Clin. Cancer Res. 12, 22722280.
  • Menon, L.G., Kuttan, R., and Kuttan, G. (1995). Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 95, 221225.
  • Menon, L.G., Kuttan, R., Nair, M.G., Chang, Y.C., and Kuttan, G. (1998). Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr. Cancer 30, 7477.
  • Menon, L.G., Kuttan, R., and Kuttan, G. (1999). Anti-metastatic activity of curcumin and catechin. Cancer Lett. 141, 159165.
  • Molife, R., and Hancock, B.W. (2002). Adjuvant therapy of malignant melanoma. Crit. Rev. Oncol. Hematol. 44, 81102.
  • Naldi, L., Gallus, S., Tavani, A., Imberti, G.L., and La Vecchia, C. (2004). Risk of melanoma and vitamin A, coffee and alcohol: a case-control study from Italy. Eur. J. Cancer Prev. 13, 503508.
  • Nihal, M., Ahmad, N., Mukhtar, H., and Wood, G.S. (2005). Anti-proliferative and proapoptotic effects of (−)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int. J. Cancer 114, 513521.
  • Nihal, M., Ahsan, H., Siddiqui, I.A., Mukhtar, H., Ahmad, N., and Wood, G.S. (2009). (−)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma. Cell Cycle 8, 20572063.
  • Nihal, M., Roelke, C.T., and Wood, G.S. (2010). Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (−)-epigallocatechin-3-gallate (EGCG). Pharm. Res. 27, 11031114.
  • Niles, R.M. (2003). Vitamin A (retinoids) regulation of mouse melanoma growth and differentiation. J. Nutr. 133, 282S286S.
  • Niles, R.M., Mcfarland, M., Weimer, M.B., Redkar, A., Fu, Y.M., and Meadows, G.G. (2003). Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett. 190, 157163.
  • Niles, R.M., Cook, C.P., Meadows, G.G., Fu, Y.M., Mclaughlin, J.L., and Rankin, G.O. (2006). Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth. J. Nutr. 136, 25422546.
  • Odot, J., Albert, P., Carlier, A., Tarpin, M., Devy, J., and Madoulet, C. (2004). In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int. J. Cancer 111, 381387.
  • Ogiwara, K., and Hata, K. (2009). Melanoma cell differentiation induced by lupeol separates into two stages: morphological and functional changes. J. Nat. Med. 63, 323326.
  • Ohga, N., Hida, K., Hida, Y., Muraki, C., Tsuchiya, K., Matsuda, K., Ohiro, Y., Totsuka, Y., and Shindoh, M. (2009). Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells. Cancer Sci. 100, 19631970.
  • Osmond, G.W., Augustine, C.K., Zipfel, P.A., Padussis, J., and Tyler, D.S. (2010). Enhancing melanoma treatment with resveratrol. J. Surg. Res. doi: 10.1016/j.jss.2010.07.033.
  • Pfahlberg, A., Kolmel, K.F., and Gefeller, O. (2001). Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation-induced melanoma. Br. J. Dermatol. 144, 471475.
  • Philip, S., and Kundu, G.C. (2003). Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J. Biol. Chem. 278, 1448714497.
  • Pichichero, E., Cicconi, R., Mattei, M., and Canini, A. (2011). Chrysin-induced apoptosis is mediated through p38 and Bax activation in B16-F1 and A375 melanoma cells. Int. J. Oncol. 38, 473483.
  • Pisano, M., Pagnan, G., Dettori, M.A. et al. (2010). Enhanced anti-tumor activity of a new curcumin-related compound against melanoma and neuroblastoma cells. Mol. Cancer 9, 137.
  • Rauth, S., Kichina, J., and Green, A. (1997). Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53. Br. J. Cancer 75, 15591566.
  • Ravindranath, M.H., Ramasamy, V., Moon, S., Ruiz, C., and Muthugounder, S. (2009). Differential growth suppression of human melanoma cells by tea (Camellia sinensis) epicatechins (ECG, EGC and EGCG). Evid. Based Complement. Alternat. Med. 6, 523530.
  • Ray, S., Chattopadhyay, N., Mitra, A., Siddiqi, M., and Chatterjee, A. (2003). Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin. J. Environ. Pathol. Toxicol. Oncol. 22, 4958.
  • Record, I.R., Broadbent, J.L., King, R.A., Dreosti, I.E., Head, R.J., and Tonkin, A.L. (1997). Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro. Int. J. Cancer 72, 860864.
  • Ricotti, C., Bouzari, N., Agadi, A., and Cockerell, C.J. (2009). Malignant skin neoplasms. Med. Clin. North Am. 93, 12411264.
  • Russo, A., Cardile, V., Lombardo, L., Vanella, L., and Acquaviva, R. (2006). Genistin inhibits UV light-induced plasmid DNA damage and cell growth in human melanoma cells. J. Nutr. Biochem. 17, 103108.
  • Sagara, Y., Vanhnasy, J., and Maher, P. (2004). Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation. J. Neurochem. 90, 11441155.
  • Saleem, M., Maddodi, N., Abu Zaid, M., Khan, N., Bin Hafeez, B., Asim, M., Suh, Y., Yun, J.M., Setaluri, V., and Mukhtar, H. (2008). Lupeol inhibits growth of highly aggressive human metastatic melanoma cells in vitro and in vivo by inducing apoptosis. Clin. Cancer Res. 14, 21192127.
  • Shen, Q., Tian, F., Jiang, P., Li, Y., Zhang, L., Lu, J., and Li, J. (2009). EGCG enhances TRAIL-mediated apoptosis in human melanoma A375 cell line. J. Huazhong Univ. Sci. Technol. Med. Sci. 29, 771775.
  • Shyong, E.Q., Lu, Y., Lazinsky, A., Saladi, R.N., Phelps, R.G., Austin, L.M., Lebwohl, M., and Wei, H. (2002). Effects of the isoflavone 4′,5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage. Carcinogenesis 23, 317321.
  • Siwak, D.R., Shishodia, S., Aggarwal, B.B., and Kurzrock, R. (2005). Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104, 879890.
  • Stratton, S.P., Alberts, D.S., Einspahr, J.G. et al. (2010). A phase 2a study of topical perillyl alcohol cream for chemoprevention of skin cancer. Cancer Prev. Res. (Phila.) 3, 160169.
  • Sun, Q., Cong, R., Yan, H., Gu, H., Zeng, Y., Liu, N., Chen, J., and Wang, B. (2009). Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol. Rep. 22, 563567.
  • Suzuki, Y., and Isemura, M. (2001). Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin. Cancer Lett. 173, 1520.
  • Syed, D.N., Suh, Y., Afaq, F., and Mukhtar, H. (2008). Dietary agents for chemoprevention of prostate cancer. Cancer Lett. 265, 167176.
  • Syed, D.N., Afaq, F., Maddodi, N., Johnson, J.J., Sarfaraz, S., Ahmad, A., Setaluri, V., and Mukhtar, H. (2011). Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/beta-catenin signaling and decreased Mitf levels. J. Invest. Dermatol. doi: 10.1038/jid.2011.6.
  • Szekeres, T., Fritzer-Szekeres, M., Saiko, P., and Jager, W. (2010). Resveratrol and resveratrol analogues – structure-activity relationship. Pharm. Res. 27, 10421048.
  • Tamura, S., Bito, T., Ichihashi, M., and Ueda, M. (2003). Genistein enhances the cisplatin-induced inhibition of cell growth and apoptosis in human malignant melanoma cells. Pigment Cell Res. 16, 470476.
  • Tanaka, H., Yamanouchi, M., Miyoshi, H., Hirotsu, K., Tachibana, H., and Takahashi, T. (2010). Solid-phase synthesis of a combinatorial methylated (+/−)-epigallocatechin gallate library and the growth-inhibitory effects of these compounds on melanoma B16 cells. Chem. Asian J. 5, 22312248.
  • Tarapore, R.S., Siddiqui, I.A., Saleem, M., Adhami, V.M., Spiegelman, V.S., and Mukhtar, H. (2010). Specific targeting of Wnt/beta-catenin signaling in human melanoma cells by a dietary triterpene lupeol. Carcinogenesis 31, 18441853.
  • Tatman, D., and Mo, H. (2002). Volatile isoprenoid constituents of fruits, vegetables and herbs cumulatively suppress the proliferation of murine B16 melanoma and human HL-60 leukemia cells. Cancer Lett. 175, 129139.
  • Umeda, D., Yano, S., Yamada, K., and Tachibana, H. (2008). Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J. Biol. Chem. 283, 30503058.
  • Vaid, M., and Katiyar, S.K. (2010). Molecular mechanisms of inhibition of photocarcinogenesis by silymarin, a phytochemical from milk thistle (Silybum marianum L. Gaertn.) (Review). Int. J. Oncol. 36, 10531060.
  • Valcic, S., Timmermann, B.N., Alberts, D.S., Wachter, G.A., Krutzsch, M., Wymer, J., and Guillen, J.M. (1996). Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs 7, 461468.
  • Van Ginkel, P.R., Darjatmoko, S.R., Sareen, D., Subramanian, L., Bhattacharya, S., Lindstrom, M.J., Albert, D.M., and Polans, A.S. (2008). Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction. Invest. Ophthalmol. Vis. Sci. 49, 12991306.
  • Vartanian, A.A., Burova, O.S., Stepanova, E.V., Baryshnikov, A.Y., and Lichinitser, M.R. (2007). Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level. Melanoma Res. 17, 370379.
  • Wang, H.Z., Zhang, Y., Xie, L.P., Yu, X.Y., and Zhang, R.Q. (2002). Effects of genistein and daidzein on the cell growth, cell cycle, and differentiation of human and murine melanoma cells(1). J. Nutr. Biochem. 13, 421426.
  • Wang, L., Shen, Y., Song, R., Sun, Y., Xu, J., and Xu, Q. (2009). An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells. Mol. Pharmacol. 76, 12381245.
  • Wietrzyk, J., Opolski, A., Madej, J., and Radzikowski, C. (2000). The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors. Acta Pol. Pharm. 57(Suppl.), 58.
  • Wietrzyk, J., Boratynski, J., Grynkiewicz, G., Ryczynski, A., Radzikowski, C., and Opolski, A. (2001). Antiangiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide. Anticancer Res. 21, 38933896.
  • Wong, Y., Osmond, G., Brewer, K.I., Tyler, D.S., and Andrus, M.B. (2010). Synthesis of 4′-ester analogs of resveratrol and their evaluation in malignant melanoma and pancreatic cell lines. Bioorg. Med. Chem. Lett. 20, 11981201.
  • Wu, Y., Lin, Y., Liu, H., and Li, J. (2008). Inhibition of invasion and up-regulation of E-cadherin expression in human malignant melanoma cell line A375 by (–)-epigallocatechin-3-gallate. J. Huazhong Univ. Sci. Technol. Med. Sci. 28, 356359.
  • Yan, C., and Han, R. (1997). Suppression of adhesion-induced protein tyrosine phosphorylation decreases invasive and metastatic potentials of B16-BL6 melanoma cells by protein tyrosine kinase inhibitor genistein. Invasion Metastasis 17, 189198.
  • Yan, C.H., Chen, X.G., Li, Y., and Han, R. (1999). Effects of genistein, a soybean-derived isoflavone, on proliferation and differentiation of B16-BL6 mouse melanoma cells. J. Asian Nat. Prod. Res. 1, 285299.
  • Yang, S., and Meyskens Jr, F.L. (2005). Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma. Mol. Pharmacol. 67, 298308.
  • Yang, S., Irani, K., Heffron, S.E., Jurnak, F., and Meyskens Jr, F.L. (2005). Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol. Cancer Ther. 4, 19231935.
  • Yang, Z., Yang, S., Misner, B.J., Chiu, R., Liu, F., and Meyskens Jr, F.L. (2008). Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol. Mol. Cancer Ther. 7, 37513760.
  • Yu, T., Li, J., and Sun, H. (2010). C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro. Cancer Chemother. Pharmacol. 66, 9991003.
  • Yun, J., Lee, C.K., Chang, I.M., Takatsu, K., Hirano, T., Min, K.R., Lee, M.K., and Kim, Y. (2000). Differential inhibitory effects of sophoricoside analogs on bioactivity of several cytokines. Life Sci. 67, 28552863.
  • Zheng, M., Ekmekcioglu, S., Walch, E.T., Tang, C.H., and Grimm, E.A. (2004). Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res. 14, 165171.